Breakthrough10 Jan 2022 23:14
Given all the news with AVCT, can’t see them producing a test for at least 3-4 months now. That’s the time to adjust the LFT, undertake another study for its effectiveness and then resubmit for approval.
Can see a lot of shareholders there jumping into ODX. Was great to see that RNS and tweet today. This will give the sp some serious push in the next few weeks, so don’t be surprised if this moves back up to the 50p-70p range imo.
Mologic have always been the front runners in the LFT game and Gates wouldn’t have bought them out if he didn’t think they didn’t know what they were doing. The sp is where it is because of the incompetence of this govt and underhand procurement practices.
Great price to buy in and make money GLA